Third Affiliated Hospital, Sun Yat-Sen University: End Stage Liver Disease trials
The registry lists 10 End Stage Liver Disease studies with Third Affiliated Hospital, Sun Yat-Sen University as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 1 4Phase 2 1Phase 4 1No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- MSC-EVs in Acute/ Acute-on-Chronic Liver Failure After Liver TransplantationNot yet recruitingNCT06825572Phase 1
- Individual Nutrition Support in HBV-ACLF Patients at Nutrition RiskRecruitingNCT06128421Not applicable
- Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLFRecruitingNCT04597164
- Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLFRecruitingNCT03920618Not applicable
- Phase I Trial of QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs in Acute-on-Chronic Liver FailureActive, not recruitingNCT06996392Phase 1
- The Safety and Efficacy of MSC-EVs in Acute/Acute-on-Chronic Liver FailureWithdrawnNCT05940610Phase 1/2
- MSC-EV in Acute-on-Chronic Liver Failure After Liver TransplantationWithdrawnNCT05881668Phase 1
- Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS TreatmentStatus unknownNCT05382013Phase 4
- Early Postoperative CRRT After Liver Transplantation in ACLF Patients With Overt HEStatus unknownNCT04317222Not applicable
- RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLFStatus unknownNCT04195282Not applicable